LDLR and diabetes mellitus: However, in the setting of LDLR ASO treatment and diabetes, we observed a dramatic increase in Oil Red O staining and perilipin 2 staining (Figure 3, A–D), consistent with the findings from human diabetic nephropathy, providing evidence that the accumulating lipids are non-HDL-associated lipids.